Sanofi Provides Key Information on Voting Rights and Shares
Sanofi has released meaningful insights into its total number of voting rights and shares, essential information for stakeholders. This data is provided according to the regulations stipulated by the French Commercial Code and the guidelines of the French stock market authority. Understanding these figures can be crucial for investors keeping an eye on the company's governance and capital structure.
Overview of Sanofi
Sanofi operates as a French société anonyme, boasting a registered share capital of approximately €2.45 billion. The company’s registered office is located in Paris, and it is officially registered under the number 395 030 844 at the Paris Commercial and Companies Registry. This underscores Sanofi's established presence and commitment within the pharmaceutical industry.
Key Figures from the Latest Report
On the significant date of August 31, 2025, Sanofi reported a total of 1,227,469,992 issued shares. This figure is critical as it reflects the volume of shares available to the shareholders and the market. Furthermore, the number of real voting rights, which excludes treasury shares, stands at 1,352,853,696. These numbers are indicative of the company's overall shareholder equity and its capacity to mobilize votes during shareholder meetings.
Insights on Theoretical Voting Rights
Including treasury shares, Sanofi also reported a theoretical number of voting rights totaling 1,361,794,887. This higher number indicates the maximum potential voting influence shareholders could have, emphasizing the importance of treasury shares in corporate governance. This information plays a pivotal role in understanding shareholder power and influence within the company.
Importance of This Data for Investors
For investors, having access to information concerning shares and voting rights is paramount. This transparency allows shareholders to make informed decisions regarding their investments and to gauge the company's governance practices. Understanding the voting rights attached to shares can also influence investment strategies, particularly for those interested in participating in corporate governance.
Contacting Sanofi for Investor Relations
Investors wishing to delve deeper into Sanofi's shareholder information or seeking assistance can reach out to the Investor Relations Department. They can be contacted via email at investor.relations@sanofi.com. It's advisable for shareholders to stay informed and engage with the company to maximize their investment potential.
Frequently Asked Questions
What is the significance of the voting rights data provided by Sanofi?
The voting rights data helps investors understand their potential influence on corporate decisions and overall company governance.
How many total shares does Sanofi have as of August 31, 2025?
Sanofi reported a total of 1,227,469,992 issued shares on that date.
What are theoretical voting rights, and why do they matter?
Theoretical voting rights include all shares, even treasury shares, highlighting the total voting potential shareholders have, which is critical in voting decisions.
How can I contact Sanofi's Investor Relations?
Investors can reach Sanofi's Investor Relations Department by emailing investor.relations@sanofi.com.
Where can I find this information on Sanofi's shares and voting rights?
This information is officially reported by Sanofi and is accessible on their regulated information webpage, specific to shareholder data.
